نتایج جستجو برای: risk of malignancy index rmi

تعداد نتایج: 21297466  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Caroline Van Holsbeke Ben Van Calster Tom Bourne Silvia Ajossa Antonia C Testa Stefano Guerriero Robert Fruscio Andrea Alberto Lissoni Artur Czekierdowski Luca Savelli Sabine Van Huffel Lil Valentin Dirk Timmerman

PURPOSE To externally validate and compare the performance of previously published diagnostic models developed to predict malignancy in adnexal masses. EXPERIMENTAL DESIGN We externally validated the diagnostic performance of 11 models developed by the International Ovarian Tumor Analysis (IOTA) group and 12 other (non-IOTA) models on 997 prospectively collected patients. The non-IOTA models ...

Journal: :Gynecologic oncology 2011
Francis Jacob Mara Meier Rosmarie Caduff Darlene Goldstein Tatiana Pochechueva Neville Hacker Daniel Fink Viola Heinzelmann-Schwarz

OBJECTIVE About 70% of epithelial ovarian cancer patients (EOC) are diagnosed at advanced stage with a five-year survival rate of only 30%. Whilst CA125 detects peritoneally-spread disease, it has limited sensitivity for early cancers, many of which are potentially curable. METHODS We compared the new commercially available tumor marker HE4 with CA125 individually, in combination, within the ...

2017
Antonia Testa Jeroen Kaijser Laure Wynants Daniela Fischerova Caroline Van Holsbeke Dorella Franchi Luca Savelli Elisabeth Epstein Artur Czekierdowski Stefano Guerriero Robert Fruscio Ignace Vergote Tom Bourne Lil Valentin Ben Van Calster Dirk Timmerman

Background: To compare different ultrasound-based International Ovarian Tumour Analysis (IOTA) strategies and Risk of Malignancy Index (RMI) for ovarian cancer diagnosis using a meta-analysis approach of centre-specific data from IOTA 3. Methods: This prospective multicentre diagnostic accuracy study included 2403 patients with 1423 benign and 980 malignant adnexal masses from 2009 until 2012. ...

2015
Mojgan Karimi-Zarchi Shokouh Paymani Mojaver Mitra Rouhi Seyed Hossein Hekmatimoghaddam Reza Nafisi Moghaddam Pouria Yazdian-Anari Soraya Teimoori

INTRODUCTION Pelvic masses are among most the common causes of patient admission into gynecology clinics and one of the most common reasons for referral to gynecologic oncology departments due to the risk of uterine or ovarian malignancies. The aim of this study is to compare the four indices of the risk of malignancy index (RMI 1-4), as a combination of menstrual status, radiological findings,...

Journal: :Asian Journal of Medical Sciences 2023

Background: Women with adnexal masses still pose a diagnostic dilemma and require efficient triaging. The Risk of Malignancy Index (RMI) is an algorithm used for differentiation malignant from benign ovarian masses. Aims Objectives: present study aimed to evaluate the four indices RMI 1, 2, 3, 4 discriminate tumor one. Materials Methods: This cross-sectional was carried out at tertiary care hos...

Journal: :International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2007
M Kashanian R Mazinani S Jalalmanesh

[1] Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynecol 1990;97:922–9. [2] Bailey J, Tailor A, Naik R, Lopes A, Godfrey K, Hatem HM, et al. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه علامه طباطبایی 1390

insurers have in the past few decades faced longevity risks - the risk that annuitants survive more than expected - and therefore need a new approach to manage this new risk. in this dissertation we survey methods that hedge longevity risks. these methods use securitization to manage risk, so using modern financial and insurance pricing models, especially wang transform and actuarial concepts, ...

Journal: :Journal of laboratory physicians 2023

Abstract Background Inadequacy of effective sensitive and specific screening modalities results in late-stage diagnosis ovarian cancer. Cancer Antigen-125 (CA-125) individually possesses limited specificity for differentiating adnexal masses. The present study aimed to evaluate the Human Epididymis Protein 4 (HE4), Risk Ovarian Malignancy Algorithm (ROMA), Index (RMI) ameliorating sensitivity b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید